Vignette-based comparative analysis of ChatGPT and specialist treatment decisions for rheumatic patients: results of the Rheum2Guide study.

Labinsky Hannah Lea-Kristin Nagler Krusche Martin Sebastian Griewing Aries Peer Kroiß Anja Patrick-Pascal Strunz Sebastian Kuhn Schmalzing Marc Michael Gernert Johannes Knitza

Published in: Rheumatology international (2024)

GPT-4 and GPT-3.5 generated safe, high-quality treatment plans for rheumatic diseases, demonstrating promise in clinical decision support. Future research should investigate detailed standardized prompts and the impact of LLM usage on clinical decisions.

Keyphrases

clinical decision support
end stage renal disease
newly diagnosed
rheumatoid arthritis
palliative care
chronic kidney disease
artificial intelligence